Comparison of 1-Month and 12-Month Vessel Responses Between the Polymer-Free Biolimus A9-Coated Stent and the Durable Polymer Everolimus-Eluting Stent-Reference-Cited by-同舟云学术

Comparison of 1-Month and 12-Month Vessel Responses Between the Polymer-Free Biolimus A9-Coated Stent and the Durable Polymer Everolimus-Eluting Stent

Published:2022-08-25 Issue:9 Volume:86 Page:1397-1408
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Ishihara Takayuki¹,Mizote Isamu²,Nakamura Daisuke²,Okamoto Naotaka³,Shiraki Tatsuya²,Itaya Naoki⁴,Tsujimura Takuya¹,Takahara Mitsuyoshi⁵,Nakayoshi Takaharu⁴,Iida Osamu¹,Hata Yosuke¹,Nishino Masami³,Ueno Takafumi⁶,Nakatani Daisaku²,Hikoso Shungo²,Nanto Shinsuke⁷,Mano Toshiaki¹,Sakata Yasushi²,

Affiliation:

1. Kansai Rosai Hospital Cardiovascular Center

2. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

3. Division of Cardiology, Osaka Rosai Hospital

4. Division of Cardiovascular Medicine, Kurume University School of Medicine

5. Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine

6. Division of Cardiology, Fukuoka Memorial Hospital

7. Department of Cardiovascular Medicine, Nishinomiya Municipal Central Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/86/9/86_CJ-22-0098/_pdf

Reference31 articles.

1. 1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773–1780.

2. 2. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519–1521.

3. 3. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation 2016; 134: e123–e155.

4. 4. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018; 39: 213–260.

5. 5. Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J 2020; 84: 831–865.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of baseline yellow plaque assessed by coronary angioscopy on vascular response after stent implantation;Journal of Cardiology;2024-09

2. Impact of 12-Month Angioscopic Thrombi and Yellow Plaque After Drug-Eluting Stent Implantation;Circulation Journal;2024-07-11

3. Editorial: Short-term DAPT after bioabsorable polymer synergy stents;Cardiovascular Revascularization Medicine;2024-06

4. Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy;Journal of Clinical Medicine;2024-03-17

5. Neoatherosclerosis: A Distinctive Pathological Mechanism of Stent Failure;Reviews in Cardiovascular Medicine;2024-03-07